Targeted Radiopharmaceuticals Summit 2020
December 8 - 10, 2020 - DEHanson Wade
info@hansonwade.com
Phone:+442031418700
Inspired by the reinvigoration the field has seen over the last 2 years, the Targeted Radiopharmaceuticals (TRP) Summit is the primary platform for industry-led discussion of the challenges and opportunities facing developers of theranostic radio ligand therapies. Join your peers from the likes of Merck, Ipsen, Advanced Accelerator Applications, ETH Zurich, Johns Hopkins Medicine and more to explore the full potential of theragnostic radionuclide therapies within advanced oncology portfolios and gain practical insights on how to deliver meaningful clinical efficacy.
This website uses cookies to ensure you get the best experience on our website. Learn more